Press Release
|
2
| December | 2011
Research efforts rewarded by Heel
The Hans-Heinrich Reckeweg Awards for scientific studies
in complementary medicine have been awarded to Dr.
Juozas Žilinskas and Prof. Tatiana Ivanovna Glotova
Baden-Baden (Germany) – The annual Hans-Heinrich Reckeweg
Awards for outstanding scientific work in the field of
homotoxicology were handed out on Friday, November 18, 2011
in Baden-Baden by Biologische Heilmittel Heel GmbH. The
winner of the 10,000 euros Main Award was the dentist Dr.
Juozas Žilinskas from Kaunas in Lithuania. The 5,000 euros
Incentive Award was issued by Heel in recognition of the
veterinary experiments conducted by Professor Tatiana
Ivanovna Glotova and her team of researchers from Novosibirsk
in Russia.
The Hans-Heinrich Reckeweg Award has been awarded 15 times
since 1995 for outstanding scientific studies in the field of
bioregulatory medicine and homotoxicology. The founder of this
model of disease and treatment was Hans-Heinrich Reckeweg – the
name given to the award in its dual format: the Main Award and the
Incentive Award. The award ceremony was held on November 18, at
Heel headquarters in Baden-Baden, with numerous local guests and
guests from the winners’ home countries of Lithuania and Russia.
The Main Award, was given this year to Dr. Juozas Žilinskas of
Lithuania for his work ‘Inhibition of peripheral blood neutrophil
oxidative burst in periodontitis patients with a homeopathic
medication Traumeel S‘. The aim of this ‘in vitro ex vivo’ study was to
evaluate the treatment of patients with periodontitis using a product
from Heel and to demonstrate the positive effects of this treatment on
cells that normally cause tissue damage.
This was a complex comparative study on the oxidative properties of
neutrophils – the main form of white blood cells, which play a part in
our innate immune defences and contribute to the destruction of
micro-organisms – in the peripheral blood of patients. The results
demonstrated the antioxidative effects of the Heel treatment. The
study was therefore able to show that the treatment can significantly
reduce the production of “oxygen radicals” by neutrophils, which if
produced in too large quantities can cause tissue damage.
Page 1 of 3
The Incentive Award, valued at 5,000 euros, was given to Prof.
Tatiana Glotova and the team of the Institute of Experimental
Veterinary Science of Siberia and the Far East (Russia), for their
work “The antiviral action of Engystol, Euphorbium Compositum S,
Echinacea Compositum SN in vitro and in vivo in a veterinary
setting“. In this study, the authors demonstrated the antiviral effects
of several of Heel products on the pathogens causing diseases in
livestock that could have severe economic consequences in Russia.
The discussions that followed the ceremony highlighted the need for
further experiments and studies in the field of bioregulatory medicine
and Homotoxicology.
443 words, 2,886 characters (incl. spaces)
Heel is a pharmaceutical company that develops, manufactures and
distributes medications based on natural substances. Being the global leader
in homeopathic combination preparations, the company is also a pioneer in
the field of scientific research in natural healthcare. In cooperation with
academic institutions, Heel actively fosters the concept of Integrative
Medicine and is striving to build the bridge between homeopathy and
conventional medicine to improve patient care and health.
The ‘Biologische Heilmittel Heel GmbH’ with its corporate headquarters
located in Baden-Baden/Germany and a staff of 1,300, achieved an annual
turnover of 184 million Euros in 2010 – more than 70 percent of it outside of
Germany. Heel medications are available through subsidiaries and
distribution partners in over 50 countries around the world. www.heel.com
Photo 1 (from
left to right):
Hans-Heinrich
Reckeweg
Award ceremony
2011: Dr. Juozas
Žilinskas
(Lithuania,
winner of the
Main Award), Dr.
Ghassan
Andraos, Head
of Medicine at
Heel, Dr. Alta
Smit, Director Medical Affairs and Research at Heel, and Prof. Tatiana
Ivanovna Glotova (Russia, winner of the Incentive Award). Source:
Biologische Heilmittel Heel GmbH.
Page 2 of 3
Photo 2 (from
right): The
winner of the
Main Award, Dr.
Juozas Žilinskas
from Lithuania,
together with Dr.
Ghassan
Andraos, Head
of Medicine at
Heel, and Dr.
Alta Smit,
Director Medical
Affairs and
Research at Heel, during the 2011 Hans-Heinrich Reckeweg Awards
ceremony. Quelle: Biologische Heilmittel Heel GmbH.
Photo 3 (from
right): The
winner of the
Incentive Award,
Pr. Tatiana
Ivanovna
Glotova from
Russia, together
with Dr.
Ghassan
Andraos, Head
of Medicine at
Heel, and Dr.
Alta Smit,
Director Medical Affairs and Research at Heel, during the 2011 HansHeinrich Reckeweg Award ceremony. Source: Biologische Heilmittel Heel
GmbH.
Press contact:
Biologische Heilmittel Heel GmbH
Matthias Reinig
Head of Corporate Communication
Phone:
+49 7221 501-276
Fax:
+49 7221 501-480
E-mail:
[email protected]
Internet: www.heel.de / www.heel.com
Page 3 of 3